药物对比
Miglitol vs Lixisenatide
Miglitol（口服α-葡萄糖苷酶抑制剂）延缓碳水化合物吸收；Lixisenatide（GLP-1激动剂，常与胰岛素联用）促进胰岛素分泌。两者均治疗2型糖尿病。
此页面暂无可用的对比维度。
临床背景
Type 2 diabetes patients comparing an oral alpha-glucosidase inhibitor versus an injectable GLP-1 receptor agonist, often in insulin combination.
结论
Both Miglitol and Lixisenatide treat type 2 diabetes effectively but differ in route, mechanism, and combination use, so choice is patient-specific.
全部药物对比